Varlilumab
N/A
Report date: 2026/02/06 20:01:23
Base Information
Drug NameVarlilumab
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[41]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCelldex Therapeutics
China Registration ClassN/A
Develop Information
Active CompaniesCelldex TherapeuticsNational Cancer Institute
Inactive CompaniesRutgers University
Active Indications +[15]
Inactive Indications +[26]